For the year ending 2025-12-31, SRTA made $197,141K in revenue. $41,347K in net income. Net profit margin of 20.97%.
| Income Statement | 2025-12-31 | |||
|---|---|---|---|---|
| Revenue | 197,141 | |||
| Cost of revenue | 156,015 | |||
| Gross profit | 41,126 | |||
| Selling, general and administrative | 60,875 | |||
| Amortization of intangible assets | 2,604 | |||
| Total operating expenses | 63,479 | |||
| Operating loss from continuing operations | -22,353 | |||
| Interest income | 4,241 | |||
| Change in fair value of warrant liabilities | -4,278 | |||
| Change in fair value of assets and other liabilities | 1,037 | |||
| Realized loss from sales of short-term investments | -5,195 | |||
| Total other non-operating income | 2,287 | |||
| Net income (loss) from discontinued operations | 61,413 | |||
| Net income (loss) | 41,347 | |||
| Basic EPS | 0.5 | |||
| Diluted EPS | 0.5 | |||
| Basic Average Shares | 82,092,345 | |||
| Diluted Average Shares | 82,092,345 | |||
Strata Critical Medical, Inc. (SRTA)
Strata Critical Medical, Inc. (SRTA)